301290 东星医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-2.4304.3444.3896.25510.693
总资产报酬率 ROA (%)-2.1803.9964.0705.6519.249
投入资产回报率 ROIC (%)-2.3224.2484.3406.17910.493

边际利润分析
销售毛利率 (%)48.02649.36648.28052.27657.380
营业利润率 (%)-14.99126.55626.97626.78729.048
息税前利润/营业总收入 (%)-15.01125.93524.57526.42229.182
净利润/营业总收入 (%)-18.86322.25023.02823.46024.876

收益指标分析
经营活动净收益/利润总额(%)-88.68966.51769.86493.78893.739
价值变动净收益/利润总额(%)-45.71925.80716.5072.3771.705
营业外收支净额/利润总额(%)1.294-0.5040.0491.1610.180

偿债能力分析
流动比率 (X)6.0396.79211.4309.2093.114
速动比率 (X)5.5286.26010.6248.5892.397
资产负债率 (%)10.7679.2206.1577.55311.809
带息债务/全部投入资本 (%)5.1122.2620.4590.0710.133
股东权益/带息债务 (%)1,841.5664,283.44121,503.312139,494.75373,625.961
股东权益/负债合计 (%)825.336981.5591,519.0981,217.047739.126
利息保障倍数 (X)-85.249-53.164-10.176-38.854357.158

营运能力分析
应收账款周转天数 (天)83.00878.05992.97090.42475.245
存货周转天数 (天)215.146174.865162.681163.882169.580